Recent XRP news today shows heavy pressure on Ripple’s token as prices slid sharply in the latest market crash. XRP’s market cap has fallen significantly, and dailyRecent XRP news today shows heavy pressure on Ripple’s token as prices slid sharply in the latest market crash. XRP’s market cap has fallen significantly, and daily

XRP News: Remittix Is Capturing Tens Of Thousands Of Ripple Investors After Market Crash

2026/02/10 13:46
4 min read

Recent XRP news today shows heavy pressure on Ripple’s token as prices slid sharply in the latest market crash. XRP’s market cap has fallen significantly, and daily trading volume reflects weaker demand as investors reassess risk. While this pressure continues, many Ripple investors are shifting focus toward Remittix.

Remittix is capturing tens of thousands of investors who are seeking alternatives after the downturn. With a newly activated 300% bonus, a live wallet, and a full platform launch set for February 9, 2026, Remittix is gaining traction as one of the best cryptos to buy, combining real product progress with strong community demand.

XRP News: Remittix Is Capturing Tens Of Thousands Of Ripple Investors After Market Crash

Price Pressure Hits XRP As Sentiment Shifts

XRP is currently trading at $1.42, and its market capitalization is approximately $86 billion with a daily trading volume of $6.7 billion. The token has lost a large portion of its value amid broader crypto weakness, leading many traders to cut exposure.

Technically, XRP’s current trend shows the price testing major zones of selling pressure. Major crypto exchanges are showing supply indicators where the token’s price is dominated by selling pressure. According to XRP news today from analysts, until the token witnesses buying pressure, its price will continue to face difficulties.

Although XRP still holds its place in the crypto market, the token’s decline has led many investors to look for other tokens with better prospects for growth.

Remittix Is Gaining Attention After Ripple Downturn

As XRP faces selling pressure, many investors are turning to Remittix. Remittix is capturing tens of thousands of Ripple investors who are searching for new growth opportunities in the crypto market. The project’s momentum is driven not only by short-term incentives but also by real product milestones that are unfolding.

Remittix has sold over 708 million tokens, is priced at $0.123, and has raised more than $29.1 million, with more than 93% of available allocation already allocated. This high uptake shows strong belief among participants, especially as markets recalibrate.

A key driver for recent interest is the 300% bonus, available via email to new buyers, giving extra tokens for early engagement and building urgency in the community. The live wallet on the Apple App Store provides secure asset management today, and the full platform launch on 9 February 2026 will unlock expanded crypto-to-fiat functionality.

Security credentials differentiate Remittix from many early-stage crypto investment options. The team is fully audited and verified by CertiK, and Remittix ranks #1 on CertiK Skynet with a strong Grade A Score based on tens of thousands of community ratings, reinforcing trust and confidence.

Additionally, Remittix has secured exchange listings with BitMart and LBANK, and a third major listing awaits activation when the project hits a $30 million raise, which will further expand access and liquidity.

Remittix also offers community incentives, including a 15% USDT referral program, which supports network growth and participation. As Ripple investors reassess their portfolios amid the current downturn, Remittix’s combination of secure verification, product rollout, real adoption measures, and strong incentive design is capturing significant interest.

Why Remittix Is Gaining Traction:

  • Send crypto directly to bank accounts in seconds across many regions
  • Built for real payment use, not speculation alone
  • CertiK verified team with strong security validation
  • Mobile wallet now live with crypto-to-fiat rollout soon
  • Business API aims to onboard new liquidity and real users

Why Remittix Is Standing Out Amid XRP News

Recent XRP news shows pressure on price and demand, prompting many holders to explore other options. Remittix is capturing attention because it combines real product rollout, strong security verification, and incentives like a 300% bonus that reward early engagement.

With the 9 February 2026 platform launch approaching and the project nearing a $30 million raise that will enable its largest CEX listing yet, Remittix stands out as a top crypto under $1 for investors seeking a blend of real-world utility and growth potential after the market crash.

Discover the future of PayFi with Remittix by checking out their project here:

Website: https://remittix.io/

Socials: https://linktr.ee/remittix

Comments
Market Opportunity
XRP Logo
XRP Price(XRP)
$1.4229
$1.4229$1.4229
-1.60%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26